Zobrazeno 1 - 10
of 96
pro vyhledávání: '"maximal androgen blockade"'
Autor:
Guillaume Grisay, Fabio Turco, Saskia Litiere, Béatrice Fournier, Anna Patrikidou, Enrique Gallardo, Ray McDermott, Ahu Alanya, Silke Gillessen, Bertrand Tombal
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The landscape of treating metastatic prostate cancer has evolved with the addition of Androgen Receptor pathway inhibitor (ARPI) to Androgen Deprivation Therapy (ADT), significantly improving survival rates. However, prolonged use of these therapies
Externí odkaz:
https://doaj.org/article/81835467e73e4364af4a30938a8d05b9
Autor:
Ning Wang, Jian-Ye Liu, Xiong Li, Min-Hua Deng, Zhi Long, Jin Tang, Kun Yao, Yi-Chuan Zhang, Le-Ye He
Publikováno v:
Asian Journal of Andrology, Vol 21, Iss 1, Pp 56-61 (2019)
The pretreatment serum albumin/globulin ratio (AGR) has been used as a prognostic biomarker for various cancer types. However, the prognostic value of the AGR for prostate cancer, especially for metastatic prostate cancer (mPCa) after maximal androge
Externí odkaz:
https://doaj.org/article/af6d0c8d1038495bb8ded503f3338f89
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Erhan Demi̇relli̇, Ahmet Hakan Haliloğlu, Ömer Gülpınar, Mehmet Giray Sönmez, Yaşar Bedük, Sadettin Küpeli
Publikováno v:
Acta Medica Alanya, Vol 2, Iss 3, Pp 182-187 (2018)
Aim: In the present study we aimed to check the impact of maximal androgen deprivation therapy (MADT) on cellular blood components such as hemoglobin (Hb) and hematocrit (Htc) fasting blood glucose (FBG), serum lipid values and bone mineral density (
Externí odkaz:
https://doaj.org/article/6ec779a59d2c44a1a25d279367b63a8e
Autor:
Yong Luo, Mingchuan Li, Hengzhi Qi, Jiahui Zhao, Yili Han, Yunhua Lin, Zhu Hou, Yongguang Jiang
Publikováno v:
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background To assess the oncologic outcomes of radiation therapy (RT) combined with maximal androgen blockade (MAB) and prostate-specific antigen (PSA) kinetics in patients with localized, high-risk prostate carcinoma (PCa). Methods Three-hu
Externí odkaz:
https://doaj.org/article/705106f644fc45f98bb352e815732fe0
Autor:
Hideyuki Akaza
Publikováno v:
Prostate International, Vol 1, Iss 2, Pp 81-88 (2013)
To determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy with an luteinizing hormone releasing hormone (LHRH) analog on overall survival of prostate cancer patients in the Japan Study Group of Prostate Cancer (J-CaP)
Externí odkaz:
https://doaj.org/article/1372ccfcab4a40d68c722399ffb81317
Autor:
Xiong Li, Jin Tang, Yi-Chuan Zhang, Kun Yao, Jianye Liu, Min-Hua Deng, Zhi Long, Ning Wang, Leye He
Publikováno v:
Asian Journal of Andrology
Asian Journal of Andrology, Vol 21, Iss 1, Pp 56-61 (2019)
Asian Journal of Andrology, Vol 21, Iss 1, Pp 56-61 (2019)
The pretreatment serum albumin/globulin ratio (AGR) has been used as a prognostic biomarker for various cancer types. However, the prognostic value of the AGR for prostate cancer, especially for metastatic prostate cancer (mPCa) after maximal androge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709f150f019d4c2a8171408705a7380c
http://europepmc.org/articles/PMC6337948
http://europepmc.org/articles/PMC6337948
Publikováno v:
Journal of International Translational Medicine, Vol 4, Iss 3, Pp 160-166 (2016)
Prostate cancer is a common malignant tumor in urological system. It is also the second leading cause of high morbidity and mortality among men in Western countries. The occurrence and development of prostate cancer is a multi-factor and multi-step p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::c55a4e8e50708188ee54ed282ccca589
http://www.jitm.hk/EN/abstract/abstract212.shtml
http://www.jitm.hk/EN/abstract/abstract212.shtml
Autor:
Tadaichi Kitamura, Osamu Ogawa, Yoshihiko Hirao, Michiyuki Usami, Hideyuki Akaza, Shiro Hinotsu, Masaru Murai, Kazuhiro Suzuki, Seiji Naito, Taiji Tsukamoto, Mikio Namiki
Publikováno v:
Prostate International, Vol 1, Iss 2, Pp 81-88 (2013)
Prostate International
Prostate International
Purpose To determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy with an luteinizing hormone releasing hormone (LHRH) analog on overall survival of prostate cancer patients in the Japan Study Group of Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b8597de19593774fadfc77f0760b46
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.